Literature DB >> 27232545

Herbal medicines: challenges in the modern world. Part 3. China and Japan.

Lida Teng1, Qiang Zu2,3,4, Gangzhou Li5, Tian Yu5, Kathleen M Job5, Xiaoyan Yang6, Liuqing Di2,3,4, Catherine Mt Sherwin5,7, Elena Y Enioutina5,8.   

Abstract

INTRODUCTION: Medicinal plants, and formulations prepared from them, have been used in China and Japan for thousands of years. Nowadays, ancient formulations of Traditional Chinese and Kampo (Japanese) Medicines coexist with Western herbal medicines (HMs) and complement each other. HMs are used for the treatment of mild and chronic diseases, as an adjunct therapy, to improve wellbeing and delay aging, or as healthy (functional) foods. AREAS COVERED: This article, a third part in a series of reviews, is focusing on history, use and regulation of the traditional and modern HMs in Japan and China. Materials available from legislative and governmental websites, PubMed and news media were used. Expert commentary: HMs are heavily regulated in both countries, often in a similar manner as conventional pharmaceutical drugs. The majority of herbal formulations are sold as over-the-counter medications supplied with leaflets describing indications and appropriate dosages for patients of different ages. Medical practitioners prescribe herbal formulations that are tailored to the needs of particular patients. Both countries had problems with adverse drug reactions and toxicity of single herbs and herbal formulations that have been investigated by authorities, and some drugs have been removed from the market.

Entities:  

Keywords:  Kampo medicine; Yin and Yang balance; five elements; five flavors; four natures; herbal medicines; meridians; regulations; safety; traditional Chinese medicine

Mesh:

Substances:

Year:  2016        PMID: 27232545     DOI: 10.1080/17512433.2016.1195263

Source DB:  PubMed          Journal:  Expert Rev Clin Pharmacol        ISSN: 1751-2433            Impact factor:   5.045


  12 in total

1.  Cultural Sensitivity and Global Pharmacy Engagement in Asia: China, Japan, South Korea, and Taiwan.

Authors:  Marina Kawaguchi-Suzuki; Miranda G Law; Jennifer Prisco; Kathleen Head; Lei Fu; Tetsuro Yumoto; Junzo Kamei; Mihi Yang; Kuei-Ju Cheng; Michael D Hogue
Journal:  Am J Pharm Educ       Date:  2019-05       Impact factor: 2.047

Review 2.  Future of Treatment for Nonalcoholic Steatohepatitis: Can the Use of Safe, Evidence-Based, Clinically Proven Supplements Provide the Answer to the Unmet Need?

Authors:  Yaron Ilan
Journal:  Dig Dis Sci       Date:  2018-04-20       Impact factor: 3.199

Review 3.  Traditional and complementary medicine for promoting healthy ageing in WHO Western Pacific Region: Policy implications from utilization patterns and current evidence.

Authors:  Vincent C H Chung; Charlene H L Wong; Claire C W Zhong; Yan Yin Tjioe; Ting Hung Leung; Sian M Griffiths
Journal:  Integr Med Res       Date:  2020-07-04

Review 4.  Nephrotoxicity and Chinese Herbal Medicine.

Authors:  Bo Yang; Yun Xie; Maojuan Guo; Mitchell H Rosner; Hongtao Yang; Claudio Ronco
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-03       Impact factor: 8.237

5.  Barriers, knowledge, and training related to pharmacists' counselling on dietary and herbal supplements: a systematic review of qualitative studies.

Authors:  Jeremy Y Ng; Umair Tahir; Simran Dhaliwal
Journal:  BMC Health Serv Res       Date:  2021-05-25       Impact factor: 2.655

6.  Bactericidal activity of alpha-bromocinnamaldehyde against persisters in Escherichia coli.

Authors:  Qingshan Shen; Wei Zhou; Liangbin Hu; Yonghua Qi; Hongmei Ning; Jian Chen; Haizhen Mo
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

7.  Application of Feedback System Control Optimization Technique in Combined Use of Dual Antiplatelet Therapy and Herbal Medicines.

Authors:  Wang Liu; Yu-Long Li; Mu-Ting Feng; Yu-Wei Zhao; Xianting Ding; Ben He; Xuan Liu
Journal:  Front Physiol       Date:  2018-05-04       Impact factor: 4.566

8.  Japanese Herbal Kampo Hochu-Ekki-To or Juzen-Taiho-To after Surgery for Hip Fracture Does Not Reduce Infectious Complications.

Authors:  Yusuke Sasabuchi; Hiroki Matsui; Alan Kawarai Lefor; Taisuke Jo; Nobuaki Michihata; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Evid Based Complement Alternat Med       Date:  2018-04-29       Impact factor: 2.629

9.  Aristolochic Acid-Induced Genotoxicity and Toxicogenomic Changes in Rodents.

Authors:  Xi-Lin Li; Xiao-Qing Guo; Hai-Rong Wang; Tao Chen; Nan Mei
Journal:  World J Tradit Chin Med       Date:  2020-03-13

10.  Integrating traditional Chinese medicines into professional community pharmacy practice in China - Key stakeholder perspectives.

Authors:  Dongning Yao; Hao Hu; Joanna E Harnett; Carolina Oi Lam Ung
Journal:  Eur J Integr Med       Date:  2020-02-05       Impact factor: 1.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.